Back to Search
Start Over
Lymphatic regulator Prox1 determines Schlemm's canal integrity and identity
- Source :
- Journal of Clinical Investigation. September 1, 2014, Vol. 124 Issue 9, p3960, 15 p.
- Publication Year :
- 2014
-
Abstract
- Introduction Schlemm's canal (SC) is an endothelium-lined vascular channel that encircles the margin of the cornea and drains aqueous humor, which is produced in the ciliary body and supplies the [...]<br />Schlemm's canal (SC) is a specialized vascular structure in the eye that functions to drain aqueous humor from the intraocular chamber into systemic circulation. Dysfunction of SC has been proposed to underlie increased aqueous humor outflow (AHO) resistance, which leads to elevated ocular pressure, a factor for glaucoma development in humans. Here, using lymphatic and blood vasculature reporter mice, we determined that SC, which originates from blood vessels during the postnatal period, acquires lymphatic identity through upregulation of prospero homeobox protein 1 (PROX1), the master regulator of lymphatic development. SC expressed lymphatic valve markers FOXC2 and integrin [α.sub.9] and exhibited continuous vascular endothelialcadherin (VE-cadherin) junctions and basement membrane, similar to collecting lymphatics. SC notably lacked luminal valves and expression of the lymphatic endothelial cell markers podoplanin and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1). Using an ocular puncture model, we determined that reduced AHO altered the fate of SC both during development and under pathologic conditions; however, alteration of VEGF-C/VEGFR3 signaling did not modulate SC integrity and identity. Intriguingly, PROX1 expression levels linearly correlated with SC functionality. For example, PROX1 expression was reduced or undetectable under pathogenic conditions and in deteriorated SCs. Collectively, our data indicate that PROX1 is an accurate and reliable biosensor of SC integrity and identity.
- Subjects :
- Complications and side effects
Development and progression
Research
Risk factors
Patient outcomes
Vascular endothelial growth factor -- Research
Hyaluronic acid -- Research
Glaucoma -- Research -- Risk factors -- Development and progression -- Patient outcomes -- Complications and side effects
Subjects
Details
- Language :
- English
- ISSN :
- 00219738
- Volume :
- 124
- Issue :
- 9
- Database :
- Gale General OneFile
- Journal :
- Journal of Clinical Investigation
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.382429632
- Full Text :
- https://doi.org/10.1172/JCI75392